If you're building a plant-based company, here are 25 investors who closed deals between 2023 and 2025. Funding dropped 64% in 2024 for plant-based, but fermentation companies pulled in 43% more capital. Some of these investors pivoted hard toward B2B ingredients.
Lever VC: Backed Gavan Technologies' $8M Series A in December 2024 for plant-based fats.
Big Idea Ventures: Invested in PlantBaby's seed round in February 2025 through Global Food Innovation Fund II.
Unovis Asset Management: Led Novameat's $19.4M Series A in September 2024 for fermented plant-based meat.
S2G Ventures: Closed $6.6B in US agrifoodtech deals in 2024, including alternative protein companies.
Five Seasons Ventures: Backed THIS with £20M Series C in June 2024 for plant-based meat expansion.
PowerPlant Ventures: Invested $7M in The Collaborative in April 2020, operates $330M Fund III.
Veg Capital: Angel to Series A fund backing early-stage plant-based meat and dairy replacements in UK.
AgFunder: Tracked $828M in innovative food investments in H1 2024, down from prior years.
Creadev: Led Nxtfood's €49M round in 2024 for French plant-based meat scale-up.
Roquette: Co-led Nxtfood's €49M financing in 2024, tripled revenue that year.
Novo Holdings: Co-led MATR Foods' €40M round in 2024, largest Danish food tech deal of the year.
European Investment Bank: Provided €20M venture debt to MATR Foods in 2024 and $36M to Formo in 2025.
CPT Capital: Led Asterix Foods' $4.2M seed round in 2024 for plant cell culture proteins.
Rhapsody Venture Partners: Led Lasso's $6.5M round in 2024 for SpinTech food processing.
Coefficient Capital: Led KoRo's €35M Series C in November 2024 for healthy snack expansion.
Sofinnova Partners: Led Novameat's oversubscribed $19.4M Series A in September 2024.
Forbion: Co-led Novameat's Series A through BioEconomy Fund in 2024.
MoreVC: Led Gavan's $8M Series A in December 2024 for zero-waste vegan fat technology.
EIT Food: Co-invested in Gavan's Series A in 2024 for Fatrix commercialization.
DarkBoot Group: Supported Gavan's incubation and Series A funding in 2024.
General Atlantic: Invested in Butternut Box's £280M round in September 2023.
Planet First Partners: Led THIS's £20M Series C equity round in June 2024.
Upfield: Co-invested in Heura's €40M Series B in February 2024.
ICL: Made additional investment in Plantible Foods' Series B in 2024.
Grok Ventures: Backed Asterix Foods' $4.2M seed round in 2024.
Most investors won't fit your company. Here's what actually matters.
Experience: Check if they've backed companies at your stage before. Dead portfolio companies are a red flag. Look at their exits, not just their websites.
Network: Co-investors matter more than individual firms. If they can't bring in follow-on funding, you're stuck. Ask their portfolio companies about intro quality.
Alignment: Plant-based purists and pragmatists don't mix well. Some funds won't touch anything with fermentation. Others only want B2B ingredients now. Figure out where they actually deploy capital.
Track record: Beyond Meat went public, but most don't. Check how many Series B rounds their portfolio companies raised. If they all died at Series A, there's your answer.
Communication: Use Ellty to share your deck with trackable links. You'll see who actually opens your financial projections. If they skip your unit economics, that's useful information.
Value-add: Most investors promise intros to retailers and co-manufacturers. Ask for three specific examples from their last deal. Generic promises mean nothing.
Identify potential investors: Look at who funded your competitors' last three rounds. Check Crunchbase for co-investors. Don't waste time on funds that haven't deployed capital since 2022.
Craft a compelling pitch: Lead with unit economics, not mission. Most investors are tired of sustainability claims without profitability paths. Show your CAC payback period in months, not theory.
Share your pitch deck: Upload to Ellty and send trackable links. Monitor which pages investors spend time on. If they skip your bioreactor data or manufacturing costs, adjust your follow-up.
Utilize your network: Warm intros close 10x more than cold emails. Find the second-degree connections on LinkedIn. Ask your angels to make intros, not your lawyers.
Attend networking events: Future Food-Tech, Good Food Conference, and AFN summits actually work. Skip the panels, focus on the hallway conversations. Investors remember founders who ask good questions.
Engage on online platforms: LinkedIn works better than Twitter for B2B. Comment on investor posts about deals, not platitudes. Show you understand their thesis. Don't pitch in DMs.
Organize due diligence: Set up an Ellty data room with your financial model, cap table, and supply agreements before they ask. It speeds up the process. Investors notice when you're organized.
Set up introductory meetings: Lead with traction metrics, not vision. Revenue growth rates, retention curves, and margin expansion matter. Vision gets you the meeting. Numbers get you the term sheet.
Plant-based funding dropped 64% in 2024, but fermentation grew 43%. The market corrected from 2021's hype. Companies that raised at crazy valuations are doing down rounds now.
Investors shifted toward B2B ingredients that replace animal proteins at lower cost. Consumer brands need stronger unit economics than two years ago. Profitability timelines matter more than market size claims. Most funds want to see positive contribution margin before Series A.
Early-stage alternative protein specialist with consistent deal flow since 2018.
Global food tech accelerator and investor with 130+ portfolio companies.
Alternative protein leader managing New Crop Capital Trust and NCAP Fund II.
Multi-stage firm focused on food, agriculture, oceans, and energy sectors.
Pan-European consumer brands fund specializing in food tech investments.
Growth equity firm investing $15M-$40M in plant-centric consumer brands.
UK family fund providing Angel to Series A capital for animal-free food companies.
Leading agrifoodtech investor and research platform tracking global deals.
French family office and investment firm backing sustainable food businesses.
Plant-based ingredient manufacturer with strategic investment arm.
Danish investment firm backing life science and biotech with food tech focus.
EU development bank providing venture debt and grants to food tech.
Seed-stage investor focused on food tech and sustainable solutions.
Early-stage VC backing food innovation and health tech companies.
Consumer-focused fund investing in food, beverage, and wellness brands.
European biotech and life sciences investor expanding into food tech.
Dutch VC firm managing BioEconomy Fund for sustainable food investments.
Israeli VC firm backing deep tech and food innovation companies.
European innovation community supporting sustainable food system transformation.
Private equity firm focused on sustainable food and biotech investments.
Global growth equity firm with consumer and tech focus expanding into food.
UK-based impact investor focused on plant-based and sustainable businesses.
Plant-based food company with venture arm investing in category adjacencies.
Specialty minerals company investing in alternative protein supply chain.
Australian investment firm backing technology and sustainable food companies.
These 25 investors closed deals between 2023 and 2025, but that doesn't mean they'll fund your company. Most passed on hundreds of deals to make the few you see listed. Use Ellty to share your deck with trackable links so you know who's actually interested. Track which investors open your financials vs. your mission slide.
The market shifted from consumer brands to B2B ingredients. Investors want to see paths to profitability, not just market size. Fermentation companies raised more than plant-based meat in 2025 because unit economics worked better. If you're building a consumer brand, you need retention curves and contribution margin before most of these funds will take your call. If you're building ingredients, focus on price parity with animal proteins and supply chain integration. That's what closed deals last year.